Autres langues PaxMedica, Inc.

Actions

PXMD

US70424C2035

Marché Fermé - OTC Markets Autres places de cotation 21:19:05 06/06/2024			Varia. 5j.	Varia. 1 janv.
0,321 ^USD	0,00 %		-0,31 %	-57,60 %

13/05	PaxMedica, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
23/04	Paxmedica, Inc. répond à une demande urgente de suramine intraveineuse et s'engage à fournir un accès immédiat au PAX-101	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101	15/05
PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy	07/05
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index	06/05
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index	01/05
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast	26/04
Paxmedica, Inc. Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23/04
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23/04
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
Sector Update: Health Care Stocks Slipping Late Afternoon	12/04
Top Midday Gainers	12/04
Major US Banks' Lower Earnings Drag Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	12/04
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission	11/04
PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission	11/04
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K	22/03
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments	13/03
PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02
Certain Common Stock of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PaxMedica, Inc.

Actions

PXMD

US70424C2035

Autres langues

Filtres